Real-life Experience of Bimekizumab in 27 Obese Patients With Plaque-type Psoriasis: a 24-week Multicenter Retrospective Study

Real-life Experience of Bimekizumab in 27 Obese Patients With Plaque-type Psoriasis: a 24-week Multicenter Retrospective Study

Saved in:

Bibliographic Details
Main Authors:	Zeno Fratton, Vincenzo Maione, Stefano Bighetti, Luca Bettolini, Giuseppe Stinco, Enzo Errichetti
Format:	Article
Language:	English
Published:	Mattioli1885 2025-01-01
Series:	Dermatology Practical & Conceptual
Subjects:	obese bimekizumab psoriasis safety biologic
Online Access:	https://dpcj.org/index.php/dpc/article/view/4893
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and safety of ustekinumab in the treatment of moderate to severe plaque psoriasis in Singapore
by: Wai Sze Agnes Chan, et al.
Published: (2023-07-01)

Reactivation of latent hepatitis B infection during immunosuppressive therapy with guselkumab for plaque psoriasis: a case report
by: Elena Franchi, et al.
Published: (2023-12-01)

Beyond the dichotomy: understanding the overlap between atopic dermatitis and psoriasis
by: Mengmeng Li, et al.
Published: (2025-02-01)

Geriatric Psoriasis: Evaluation of Clinical Features, Disease Course, and Treatment Modalities of Patients from a Tertiary Care Hospital
by: Elif Çalışkan, et al.
Published: (2025-01-01)

CONDITIONS OF SKIN AND INTESTINE MICROBIOTES IN PATIENTS WITH PSORIASIS
by: Ya.O. Yemchenko, et al.
Published: (2022-04-01)

Managing pediatric psoriasis: update on treatments and challenges—a review
by: A. A. Hebert, et al.
Published: (2022-07-01)

FEATURES OF THE CLINICAL COURSE OF PSORIASIS IN PATIENTS WITH OBESITY
by: Ya.O. Yemchenko, et al.
Published: (2020-04-01)

Assessing Psychosocial Burden in Psoriasis Patients Using the PRISM-RII Tool: A Comprehensive Evaluation
by: Elif Afacan Yıldırım, et al.
Published: (2025-01-01)

Effectiveness and Safety of Spesolimab in Patients with Generalized Pustular Psoriasis: A Single-centre Retrospective Study
by: Yoshiki Okada, et al.
Published: (2025-02-01)

PEPITEM, its tripeptide pharmacophores and their peptidomimetic analogues regulate the inflammatory response through parenteral and topical dosing in models of peritonitis and psoriasis
by: Anella Saviano, et al.
Published: (2025-03-01)

Biological therapy in the reduction of cardiovascular risk in patients with psoriasis
by: Andrés Tirado-Sánchez
Published: (2025-01-01)

Real-Life Analysis of Therapeutic Management and Its Correlation With the Dermatology Life Quality Index Score in 108 Patients With Pustular Psoriasis: An Italian Monocenter Study
by: Dario Buononato, et al.
Published: (2025-01-01)

Gender-related Therapeutical Response to Apremilast: New Insights in a Tailored Management of Psoriasis
by: Emanuele Trovato, et al.
Published: (2025-01-01)

Crusted Scabies in a Patient being Treated with Spesolimab for Generalized Pustular Psoriasis
by: Hanna Schratter, et al.
Published: (2025-02-01)

Generalized pustular psoriasis: a multicentric study on patient characteristics and clinical burden
by: Cristina Bulai Livideanu, et al.
Published: (2025-02-01)

Causal Relationship Between Psoriasis and Bullous Pemphigoid: A Mendelian Randomization Analysis
by: Xiaoxue Wang, et al.
Published: (2025-01-01)

A New Diagnosing Method for Psoriasis From Exhaled Breath
by: Bilge Han Tozlu, et al.
Published: (2025-01-01)

Treatment goals and preferences of pediatric psoriasis patients, young adults, and parents
by: Mirjam J. Schaap, et al.
Published: (2022-07-01)

Association between the exposure to brominated flame retardants and psoriasis risk among U.S. adults: A population-based study
by: Jingbo Zhang, et al.
Published: (2025-02-01)

Psoriasis: Unraveling Disease Mechanisms and Advancing Pharmacological and Nanotechnological Treatments
by: Miao M, et al.
Published: (2025-02-01)

CIRCADIAN RHYTHM AND INDICATORS OF SYSTEMIC INFLAMMATION IN PATIENTS WITH PSORIASIS AND CONCOMITANT ALIMENTARY OBESITY
by: Ya.O. Yemchenko, et al.
Published: (2021-04-01)

Risankizumab Versus Secukinumab: A Real-World Efficacy and Cost per Responder Comparison in Patients With Psoriasis in Italy
by: Federico Pirro, et al.
Published: (2025-01-01)

Lack of reactivation of tuberculosis in patients with psoriasis treated with secukinumab in a real-world setting of latent tuberculosis infection
by: Matteo Megna, et al.
Published: (2022-07-01)

Hyperglycemia Is a Potential Prognostic Factor for Exacerbation in Severe Psoriasis with Diabetes or Prediabetes
by: Yongpisarn T, et al.
Published: (2025-02-01)

The influence of uterine leiomyomatosis on the onset of psoriasis: a nationwide population-based study of 2.5 million Korean females
by: Yeong Ho Kim, et al.
Published: (2025-02-01)

Long-term maintenance treatment of psoriasis: the role of calcipotriol/betamethasone dipropionate aerosol foam in clinical practice
by: Gabriella Fabbrocini, et al.
Published: (2022-07-01)

Obesity mediates the association between psoriasis and diabetes incidence: a population-based study
by: Zuojiao Xu, et al.
Published: (2025-02-01)

Patients With Isolated Nail Psoriasis Are at Increased Risk for Asthma Compared to Controls in a Retrospective Cohort Study at a Single Academic Institution
by: Rachel C Hill, et al.
Published: (2025-01-01)

Serum drug levels and anti-drug antibodies in the context of dose tapering by interval prolongation of adalimumab, etanercept and ustekinumab in psoriasis patients: results of the CONDOR trial
by: Selma Atalay, et al.
Published: (2022-07-01)

Neuroimmunology of psoriasis: Possible roles for calcitonin gene-related peptide in its pathogenesis
by: Joshua Kotlyar, et al.
Published: (2025-03-01)

Sex Disparities of Health-related Quality of Life in Moderate to Severe Psoriasis: A Real-world Analysis from the Swiss Psoriasis Registry (SDNTT)
by: Ramtin Lichtenberger, et al.
Published: (2025-02-01)

Clinical profiling of psoriatic arthritis: an observational cross-sectional study from Karnataka Psoriatic Arthritis Cohort
by: Chanakya Kodishala, et al.
Published: (2022-01-01)

Dermoscopic Features of Anogenital Verrucous Carcinoma
by: Enrico Zelin, et al.
Published: (2025-01-01)

Efficacy and safety of Janus kinase inhibitors in the treatment of psoriasis and psoriatic arthritis: An analysis of evidence from 2014 to 2022
by: Jiao Wang, et al.
Published: (2025-02-01)

Multiple Basal Cell Carcinomas Arising in Nevus Sebaceous
by: Ugnè Tiskeviciute, et al.
Published: (2025-01-01)

Effect of Oral PUVAsol on the Quality of Life in Indian Patients Having Chronic Plaque Psoriasis
by: Pratik Gahalaut, et al.
Published: (2014-01-01)

Psoriatic Isomorphic Response From Molluscum Contagiosum
by: Iswariya Jaganathan, et al.
Published: (2025-01-01)

Nü Jidu in Matthew 24:27: An exegetical evaluation of Dongfang Shandian in China
by: Harman Z. Laia, et al.
Published: (2025-01-01)

Relative Importance of Mode of Administration in Treatment Preferences among Plaque Psoriasis Patients in the United States
by: Steven R. Feldman, et al.
Published: (2016-08-01)

Plain Language Summary of Publication: The ProLOGUE study investigating brodalumab in people with plaque psoriasis
by: Shinichi Imafuku, et al.
Published: (2025-01-01)